3. Multiple myeloma, or blood plasma cancer, is characterized by increased blood vessel formulation (angio- genesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient's own stem cells. The following data (stored in Myeloma ) repre- sent the bone marrow microvessel density for patients who had a complete response to the stem cell transplant (as measured by blood and urine tests). The measurements were taken immediately prior to the stem cell transplant and at the time the complete response was determined. a. At the 0.05 level of significance, is there evidence that the mean bone marrow microvessel density is higher before the stem cell transplant than after the stem cell transplant? b. Interpret the meaning of the p-value in (a). Patient Before After 158 284 189 214 202 101 JaUAWNE 353 227 416 290 426 176 441 290 Source: Data extracted from S. V. Rajkumar, R. Fonseca, T. E. Witzig, M. A. Gertz, and P. R. Greipp, "Bone Marrow Angiogenesis in Patients Achieving Complete Response After Stem Cell Transplantation for Multiple Myeloma," Leukemia, 1999, 13, pp. 469-472